Patent lawsuits are to patent lawyers what wars are to military/arms manufacturing
"So what we have here is a bunch of lawyers basically demanding that US Congress revisits AIA, cherry-picks Oil States, and makes PTAB's life (or work or profession) a lot harder."Techrights does not oppose patents; it opposes patent maximalism. It's against that scourge of bad patents granted purely for the sake of granting more patents. EPO examiners 'get' it, but the EPO's management keeps threatening them if they don't embrace patent maximalism and that is a profound threat.
Today's first post concerns PTAB because Watchtroll, an anti-PTAB site, has just written about ECCO v Skechers (a case mentioned here earlier this month in passing, with only some sketchy details about Skechers). Watchtroll took note of PTAB's relevance to Skechers:
Skechers has also been an avid user of the Patent Trial and Appeal Board (PTAB) to challenge the validity of patents held by either Nike or Adidas. To date, Skechers has filed a total of 20 petitions for inter partes review (IPR) at the PTAB. Not once has it been in front of the PTAB as a patent owner defending the validity of its own patents.
In the AIA, Congress gave any person other than the patent owner the substantive right to petition the government to take a second look at a previously issued patent franchise in an IPR proceeding. 35 U.S.C. €§ 311(a); see also Oil States, slip op. at 2. Congress further expressly provided that a party dissatisfied with the Board’s decision in such a proceeding can seek judicial review by the Federal Circuit and be a party in such an appeal. 35 U.S.C. €§ 319; see also Oil States, slip op. at 4.
Thus, Congress created a statutory right (the right to file a petition and if instituted obtain a proper final written decision), which if deprived confers standing on the petitioner, even if the petitioner “would have suffered no judicially cognizable injury in absence of the statute.” Warth, 422 U.S. at 514; see also Linda R.S., 410 U.S. at 617 n.3. The Federal Circuit’s holdings in Consumer Watchdog, Phegnix and RPX to the contrary are wrong and should be reversed.
In Medtronic Inc. v. Mark Barry, the PTAB confirmed the patentability of some of Barry’s patented back-straightening claims found in U.S. Patent Nos. 7,670,358 and 7,776,072. The saving-grace for Barry was a PTAB ruling that a set of Videos and Slides distributed by Medtronic did not count as prior art “printed publications” because they were not sufficiently publicly accessible prior to Barry’s application filing. On appeal, however, the Federal Circuit has vacated the lower tribunal opinion — holding that the Board did not consider all the relevant factors in its determination.
Section 102 of the patent act establishes “printed publications” as a form of prior art.
Unified is pleased to announce the PATROLL crowdsourcing contest winner, Rajesh Singh, who received a cash prize of $2000 for his prior art submission for U.S. Patent 7,526,477, owned by Red River Innovations, LLC, a, NPE. The '477 patent, directed to an electronic text recommendation system, has been asserted in multiple district court cases. To help the industry fight bad patents, we have published the winning prior art below.
On June 11, 2018, the Patent Trial and Appeal Board (PTAB) instituted trial on all challenged claims in an IPR filed by Unified against U.S. Patent 7,092,671 owned and asserted by Uniloc Luxembourg, SA, a well-known NPE. The '671 patent, directed to an automated telephone dialing system, has been asserted in multiple district court cases against such companies as Apple and Samsung.
Typical initial setup of a patent infringement lawsuit: the patentee (Stone’) sued Cook for infringement; Cook then requested an inter partes of the asserted patent. What happened next was odd — after Cook refused a $150k settlement, Stone conceded the IPR (all claims then cancelled) as well as the lawsuit (dismissed with prejudice).
Note here that the invention looks pretty cool – an endoscope with a basket-type device for extracting stones from a human body — such as ureteral, kidney, or gall stones. U.S. Patent No. 6,551,327. The problem apparently is the invention’s lack of novelty.
The chart below is a follow-up my prior post involving teams of inventors. The chart shows the average number of inventors per utility patent. For patents issued in first five-months of 2018, about 5% have 7 or more inventors.